机构:[1]Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, 106, Zhongshan Er Rd, Guangzhou, 510080, China广东省人民医院[2]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111, Dade Rd, Guangzhou, 510120, China大德路总院广东省中医院[3]MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, Jinan University, 601, Huang-Pu Avenue West, Guangzhou, 510632, China
Financial support for this research was provided by the Ministry of Science and Technology of China “National key research and development program” [2017YFA0505000, 2018YFC0910200]; Guangdong Key Research and Development Program [2019B020226001]; the Distinguished Young Talent Award of National High-level Personnel Program of China; and the National Natural Science Foundation of China [81502439]. They had no role in the design of the study; collection, analysis, and interpretation of the data; or writing of the manuscript.
第一作者机构:[1]Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, 106, Zhongshan Er Rd, Guangzhou, 510080, China[2]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111, Dade Rd, Guangzhou, 510120, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Huan Lin,Gong Zhang,Xu-chao Zhang,et al.Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees[J].BMC CANCER.2020,20(1):doi:10.1186/s12885-020-07528-3.
APA:
Huan Lin,Gong Zhang,Xu-chao Zhang,Xin-lei Lian,Wen-zhao Zhong...&Yi-long Wu.(2020).Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees.BMC CANCER,20,(1)
MLA:
Huan Lin,et al."Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees".BMC CANCER 20..1(2020)